Search

Zhu, Zhuoting, Leon Ellwein, Sean Wang, Jialiang Zhao, and Mingguang He. 2019. “Meeting the Need for Corrective Spectacles in Visually Impaired Chinese School Children: The Potential of Ready-Made Spectacles”. Br J Ophthalmol 103 (8): 1106-11.

Lin, Michael, Abdulrahman Rageh, Angela Turalba, Hang Lee, Iryna Falkenstein, Ambika Hoguet, Pallavi Ojha, et al. 2019. “In Reply: Protocol For Titrated Endocycloplasty When Combined With Phacoemulsification in an Exclusive Cohort of Angle Closure Glaucoma”. J Glaucoma 28 (12): e178-e179.

Bressler, Neil, Wesley Beaulieu, Susan Bressler, Adam Glassman, Michele Melia, Lee Jampol, Chirag Jhaveri, et al. 2020. “ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY AND RISK OF TRACTION RETINAL DETACHMENT IN EYES WITH PROLIFERATIVE DIABETIC RETINOPATHY: Pooled Analysis of Five DRCR Retina Network Randomized Clinical Trials”. Retina 40 (6): 1021-28.

Mayro, Eileen, Mengyu Wang, Tobias Elze, and Louis Pasquale. 2020. “The Impact of Artificial Intelligence in the Diagnosis and Management of Glaucoma”. Eye (Lond) 34 (1): 1-11.

Deng, Sophie, Vincent Borderie, Clara Chan, Reza Dana, Francisco Figueiredo, José Gomes, Graziella Pellegrini, Shigeto Shimmura, and Friedrich Kruse. 2019. “Reply”. Cornea 38 (12): e56-e57.

Sauvage, Félix, Juan Fraire, Katrien Remaut, Sebag, Karen Peynshaert, Michael Harrington, Frans Van de Velde, et al. 2019. “Photoablation of Human Vitreous Opacities by Light-Induced Vapor Nanobubbles”. ACS Nano 13 (7): 8401-16.

Douglas, Konstantinos Aa, Vivian Paraskevi Douglas, and Dean Cestari. 2019. “Neuro-Ophthalmic Manifestations of the Phakomatoses”. Curr Opin Ophthalmol 30 (6): 434-42.

BJ, Barry, Whitman MC, Hunter DG, and Engle EC. 2019. “Duane Syndrome”. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. 2019.

Yong, and Hatch. 2019. “Corneal Cross-Linking: An Effective Treatment Option for Pellucid Marginal Degeneration”. Semin Ophthalmol, 1-6.

Douglas, Vivian Paraskevi, Konstantinos Aa Douglas, and Dean Cestari. 2019. “Immune Checkpoint Inhibitors: What Neuro-Ophthalmologists Need to Know”. Curr Opin Ophthalmol 30 (6): 426-33.